Vimarsana
Biggest News Aggregation in the World

Kees Melief News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kees Melief. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kees Melief Today - Breaking & Trending Today

How can cancer care be improved? - Vimarsana News

How can cancer care be improved?

Labiotech recently asked several experts the same question on how to improve cancer care, for a special newsletter marking World Cancer Day. 

Beyond Biotech podcast 5: ANeuroTech, ISA Pharmaceuticals, LifeLength - Vimarsana News

Beyond Biotech podcast 5: ANeuroTech, ISA Pharmaceuticals, LifeLength

This week’s guests are Erik Buntinx, ANeuroTech; Stephen J. Matlin, Life Length; and Kees Melief, ISA Pharmaceuticals.

Investegate |Scancell Hlds Announcements | Scancell Hlds: Modi-1 Phase I/II CTA approved by MHRA - Vimarsana News

Investegate |Scancell Hlds Announcements | Scancell Hlds: Modi-1 Phase I/II CTA approved by MHRA

Investegate announcements from Scancell Hlds, Modi-1 Phase I/II CTA approved by MHRA

ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines - Vimarsana News

ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines

ISA Pharmaceuticals Co-authors Publication in Nature Reviews Cancer on Therapeutic Cancer Vaccines LEIDEN, Netherlands, May 4, 2021 /PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical-stage immunotherapy company dedicated to developing immunotherapeutics for oncology and infectious diseases, announces publication in Nature Reviews Cancer of a review of therapeutic cancer vaccines. The paper is co-authored by ISA's Chief Scientific Officer, Prof. Cornelis "Kees" Melief in collaboration with key opinion leaders at international institutions including the Icahn School of Medicine at Mount Sinai...